IMPACT-FFRNCT03030495
Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR
StatusActive, Not Recruiting
PhaseNot specified
SponsorSamsung Medical Center
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 6 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026 Show 4 more changesShow less
- Eligibility criteria shortened, about 10 words
- Secondary endpoints: details revised at 3 of 15 entries
- Study description revised
- Site details revised at 1 of 4 sites
- Notable Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025
- Start date: Dec 2016 to Dec 1, 2016
- Notable Primary completion date: Dec 2023 to Dec 31, 2024
- Study completion date: Dec 2024 to Dec 31, 2024
Notable Primary completion date: Dec 2022 to Dec 2023v5 Show 4 more changesShow less
- Trial status: Recruiting to Active, Not Recruiting
- Study completion date: Dec 2023 to Dec 2024
- Site details revised at 4 of 4 sites
- Collaborators revised (4)
- Notable Primary completion date: Dec 2019 to Dec 2022
- Study completion date: Dec 2020 to Dec 2023
- Site details revised at 1 of 4 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
patient-oriented composite outcome
Timeframe: 24 months
Secondary (14)
patient-oriented composite outcome
All-cause death
cardiac death
Target-vessel nonfatal MI
Non-target vessel nonfatal MI
Show 9 moreShow less
All-cause nonfatal MI
Seattle Angina Questionnaires
Change in normalized total atheroma volume
Change in total atheroma volume index
Change in fibrous cap thickness by OCT
Change in Plaque burden at minimum lumen area site
Change in Fractional flow reserve
Change in coronary flow reserve
Change in index of microcirculatory resistance
Arms and interventions
Overt microvascular disease
Fractional flow reserve\>0.80, coronary flow reserve\<2 \& Index of microvascular resistance\>25U
No Overt microvascular disease
Fractional flow reserve\>0.80, coronary flow reserve\>2 \& Index of microvascular resistance\<25U
Devices: Comprehensive physiologic evaluation, Intravascular imaging devices
Sites
4 sites in 1 country